... Currently however, there areno human peptide-based cancer vaccines on the market,mostly resulting from difficulties associated with theirpoor immunogenicity, stability and delivery. We [22,23]and ... -microglobulin complexes on the D C surface, espe-cially when the antigen-derived peptides are bound from the outside and not processed [31].It is therefore essential that the vaccine-carrier sys-tems ... Qa-1 [8,9]. These cells arephysiologically primed and operate in unison to assist inrecovery from T cell-mediated experimental autoimmuneencephalomyelitis in H-2umice [10,13,14]. Interestingly,recent...